Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
Ab105544-10μl | 10μl | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $66.90 | |
Ab105544-50μl | 50μl | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $198.90 | |
Ab105544-100μl | 100μl | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $297.90 | |
Ab105544-1ml | 1ml | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,107.90 |
Recombinant (EP3070); Rabbit anti Human Glukagon Antibody; IHC; Unconjugated
Product Name | Recombinant Glukagon Antibody - Primary antibody, specific to Human, IgG |
---|---|
Synonyms | GCG antibody |
Specifications & Purity | ExactAb™, Validated, Recombinant, 0.3 mg/mL |
Host species | Rabbit |
Specificity | Human |
Immunogen | Synthetic peptide within Human Glucagon aa 50-150 (N terminal). The exact sequence is proprietary. |
Positive Control | IHC: Human pancreas tissue |
Conjugation | Unconjugated |
Grade | ExactAb™, Recombinant, Validated |
Product Description | Recombinant antibody (EP3070) to Glukagon, could be used for IHC and so on. |
Isotype | IgG |
---|---|
Light Chain Type | kappa |
SDS-PAGE | 150 kDa |
Purification Method | Protein A purified |
Form | Liquid |
Concentration | 0.3 mg/mL |
Storage Temp | Store at -20°C,Avoid repeated freezing and thawing |
Shipped In | Ice chest + Ice pads |
Stability And Storage | Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Application | Dilution info |
---|---|
IHC | 1/100 - 1/200 "> 1/100 - 1/200 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
ZJ23F0700717 | Certificate of Analysis | Apr 25, 2024 | Ab105544 |
ZJ23F0700718 | Certificate of Analysis | Apr 25, 2024 | Ab105544 |
1. Bell GI, Sanchez-Pescador R, Laybourn PJ, Najarian RC. (1983) Exon duplication and divergence in the human preproglucagon gene.. Nature, 304 (5924): (368-71). [PMID:6877358] [10.1021/op500134e] |
2. Rouillé Y, Bianchi M, Irminger JC, Halban PA. (1997) Role of the prohormone convertase PC2 in the processing of proglucagon to glucagon.. FEBS Lett, 413 (1): (119-23). [PMID:9287128] [10.1021/op500134e] |
3. Bonic A, Mackin RB. (2003) Expression, purification, and PC1-mediated processing of human proglucagon, glicentin, and major proglucagon fragment.. Protein Expr Purif, 28 (1): (15-24). [PMID:12651102] [10.1021/op500134e] |
4. Kim RM, Chang J, Lins AR, Brady E, Candelore MR, Dallas-Yang Q, Ding V, Dragovic J, Iliff S, Jiang G, Mock S, Qureshi S, Saperstein R, Szalkowski D, Tamvakopoulos C, Tota L, Wright M, Yang X, Tata JR, Chapman K, Zhang BB, Parmee ER.. (2008) Discovery of potent, orally active benzimidazole glucagon receptor antagonists.. Bioorg Med Chem Lett, 18 (13): (3701-3705). [PMID:18539028] [10.1016/j.bmcl.2008.05.072] |
5. Orskov, C C, Bersani, M M, Johnsen, A H AH, Højrup, P P and Holst, J J JJ.. (1989) Complete sequences of glucagon-like peptide-1 from human and pig small intestine.. The Journal of biological chemistry, (5): [PMID:2753890] |
6. Drucker, D J DJ and Asa, S S.. (1988) Glucagon gene expression in vertebrate brain.. The Journal of biological chemistry, (25): [PMID:2901414] |
7. White, J W JW and Saunders, G F GF.. (1986) Structure of the human glucagon gene.. Nucleic acids research, (25): [PMID:3725587] |
8. Orskov, C C, Wettergren, A A and Holst, J J JJ.. (1993) Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable.. Diabetes, [PMID:8482423] |
9. Sturm, N S NS and 7 more authors.. (1998) Structure-function studies on positions 17, 18, and 21 replacement analogues of glucagon: the importance of charged residues and salt bridges in glucagon biological activity.. Journal of medicinal chemistry, (16): [PMID:9667960] |
10. and Drucker DJ.. (1999) Glucagon-like Peptide 2.. Trends in endocrinology and metabolism: TEM, [PMID:10322410] |
11. Kieffer, T J TJ and Habener, J F JF.. (1999) The glucagon-like peptides.. Endocrine reviews, [PMID:10605628] |
12. Chang, Xiaoqing X, Keller, Danielle D, O'Donoghue, Seán I SI and Led, Jens J JJ.. (2002) NMR studies of the aggregation of glucagon-like peptide-1: formation of a symmetric helical dimer.. FEBS letters, (27): [PMID:11943215] |
13. Thomsen, J J, Kristiansen, K K, Brunfeldt, K K and Sundby, F F.. (1972) The amino acid sequence of human glucagon.. FEBS letters, (1): [PMID:11946536] |
14. and Drucker, Daniel J DJ.. (2003) Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.. Molecular endocrinology (Baltimore, Md.), [PMID:12554744] |
15. Jiang, Guoqiang G and Zhang, Bei B BB.. (2003) Glucagon and regulation of glucose metabolism.. American journal of physiology. Endocrinology and metabolism, [PMID:12626323] |
16. Ying, Jinfa J, Ahn, Jung-Mo JM, Jacobsen, Neil E NE, Brown, Michael F MF and Hruby, Victor J VJ.. (2003) NMR solution structure of the glucagon antagonist [desHis1, desPhe6, Glu9]glucagon amide in the presence of perdeuterated dodecylphosphocholine micelles.. Biochemistry, (18): [PMID:12627948] |
17. Cohen, Mark A MA and 8 more authors.. (2003) Oxyntomodulin suppresses appetite and reduces food intake in humans.. The Journal of clinical endocrinology and metabolism, [PMID:14557443] |
18. Tadokoro, R R and 5 more authors.. (2003) Postnatal and postprandial changes in plasma concentrations of glicentin in term and preterm infants.. Acta paediatrica (Oslo, Norway : 1992), [PMID:14632334] |
19. Brubaker, Patricia L PL and Anini, Younes Y.. (2003) Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2.. Canadian journal of physiology and pharmacology, [PMID:14719035] |
20. Hillier, Ladeana W LW and 121 more authors.. (2005) Generation and annotation of the DNA sequences of human chromosomes 2 and 4.. Nature, (7): [PMID:15815621] |
21. Ellingsgaard, Helga H and 20 more authors.. (2011) Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.. Nature medicine, (30): [PMID:22037645] |